Flurizan completed Phase 2 human trials in Alzheimer's patients, and it is also in Phase 2-b human clinical trials for treating patients with pre-metastatic prostate cancer.
That proposed phase includes development of the SM-3II B interceptor, an advanced version of the missile currently provided aboard our Aegis missile defense warships.